RET and thyroid cancer, nonmedullary, 2: A number of genetic mutations that are associated with DTC development have been identified, including RET/PTC translocations, BRAF(V600E) point mutations and RAS point mutations in PTC [15,16], with RAS point mutations and PPAR-γ and PAX8 rearrangements commonly identified in FTC [17].